120 related articles for article (PubMed ID: 6170311)
1. Conformational aspects critical to the immunospecificity of the type III group B streptococcal polysaccharide.
Jennings HJ; Lugowski C; Kasper DL
Biochemistry; 1981 Aug; 20(16):4511-8. PubMed ID: 6170311
[TBL] [Abstract][Full Text] [Related]
2. Structure and serology of the native polysaccharide antigen of type Ia group B streptococcus.
Jennings HJ; Rosell KG; Kasper DL
Proc Natl Acad Sci U S A; 1980 May; 77(5):2931-5. PubMed ID: 6156459
[TBL] [Abstract][Full Text] [Related]
3. Structure and immunochemistry of an oligosaccharide repeating unit of the capsular polysaccharide of type III group B Streptococcus. A revised structure for the type III group B streptococcal polysaccharide antigen.
Wessels MR; Pozsgay V; Kasper DL; Jennings HJ
J Biol Chem; 1987 Jun; 262(17):8262-7. PubMed ID: 3298228
[TBL] [Abstract][Full Text] [Related]
4. Immunodeterminant specificity of human immunity to type III group B streptococcus.
Kasper DL; Baker CJ; Baltimore RS; Crabb JH; Schiffman G; Jennings HJ
J Exp Med; 1979 Feb; 149(2):327-39. PubMed ID: 84042
[TBL] [Abstract][Full Text] [Related]
5. Immunochemical analysis of the types Ia and Ib group B streptococcal polysaccharides.
Schifferle RE; Jennings HJ; Wessels MR; Katzenellenbogen E; Roy R; Kasper DL
J Immunol; 1985 Dec; 135(6):4164-70. PubMed ID: 3934276
[TBL] [Abstract][Full Text] [Related]
6. Structural elucidation of type III group B Streptococcus capsular polysaccharide using molecular dynamics simulations: the role of sialic acid.
González-Outeiriño J; Kadirvelraj R; Woods RJ
Carbohydr Res; 2005 Apr; 340(5):1007-18. PubMed ID: 15780265
[TBL] [Abstract][Full Text] [Related]
7. Immunochemical analysis and immunogenicity of the type II group B streptococcal capsular polysaccharide.
Kasper DL; Baker CJ; Galdes B; Katzenellenbogen E; Jennings HJ
J Clin Invest; 1983 Jul; 72(1):260-9. PubMed ID: 6192144
[TBL] [Abstract][Full Text] [Related]
8. NMR and molecular dynamics studies of the conformational epitope of the type III group B Streptococcus capsular polysaccharide and derivatives.
Brisson JR; Uhrinova S; Woods RJ; van der Zwan M; Jarrell HC; Paoletti LC; Kasper DL; Jennings HJ
Biochemistry; 1997 Mar; 36(11):3278-92. PubMed ID: 9116006
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus.
Wessels MR; Paoletti LC; Kasper DL; DiFabio JL; Michon F; Holme K; Jennings HJ
J Clin Invest; 1990 Nov; 86(5):1428-33. PubMed ID: 2243123
[TBL] [Abstract][Full Text] [Related]
10. Immunochemical characterization of the "native" type III polysaccharide of group B Streptococcus.
Baker CJ; Kasper DL; Davis CE
J Exp Med; 1976 Feb; 143(2):258-70. PubMed ID: 55450
[TBL] [Abstract][Full Text] [Related]
11. Existence of multiple immunodeterminants in the type-specific capsular substance of group B type Ia streptococci.
Kane JA; Karakawa WW
Infect Immun; 1978 Mar; 19(3):983-91. PubMed ID: 76609
[TBL] [Abstract][Full Text] [Related]
12. Determinant specificities of the groups B and C polysaccharides of Neisseria meningitidis.
Jennings HJ; Roy R; Michon F
J Immunol; 1985 Apr; 134(4):2651-7. PubMed ID: 2579148
[TBL] [Abstract][Full Text] [Related]
13. Soluble group- and type-specific antigens from type III group B Streptococcus.
Carey RB; Eisenstein TK; Shockman GD; Greber TF; Swenson RM
Infect Immun; 1980 Apr; 28(1):195-203. PubMed ID: 6155346
[TBL] [Abstract][Full Text] [Related]
14. NMR studies of carbohydrates and carbohydrate-mimetic peptides recognized by an anti-group B Streptococcus antibody.
Johnson MA; Jaseja M; Zou W; Jennings HJ; Copie V; Pinto BM; Pincus SH
J Biol Chem; 2003 Jul; 278(27):24740-52. PubMed ID: 12700231
[TBL] [Abstract][Full Text] [Related]
15. The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B Streptococcus.
Edwards MS; Nicholson-Weller A; Baker CJ; Kasper DL
J Exp Med; 1980 May; 151(5):1275-87. PubMed ID: 6989947
[TBL] [Abstract][Full Text] [Related]
16. Isolation of type-specific polysaccharide antigen from group B type Ib streptococci.
Tai JY; Gotschlich EC; Lancefield RC
J Exp Med; 1979 Jan; 149(1):58-66. PubMed ID: 33225
[TBL] [Abstract][Full Text] [Related]
17. Multiple polysaccharide antigens of group B streptococcus, type Ia: emphasis on a sialic acid type-specific polysaccharide.
Kane JA; Karakawa WW
J Immunol; 1977 Jun; 118(6):2155-60. PubMed ID: 68081
[TBL] [Abstract][Full Text] [Related]
18. Specificity and protective activity of murine monoclonal antibodies directed against the capsular polysaccharide of type III group B streptococci.
Teti G; Calapai M; Calogero G; Tomasello F; Mancuso G; Galli A; Riggio G
Hybridoma; 1992 Feb; 11(1):13-22. PubMed ID: 1371105
[TBL] [Abstract][Full Text] [Related]
19. Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule.
Wessels MR; Rubens CE; Benedí VJ; Kasper DL
Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8983-7. PubMed ID: 2554337
[TBL] [Abstract][Full Text] [Related]
20. Effects of chain length on the immunogenicity in rabbits of group B Streptococcus type III oligosaccharide-tetanus toxoid conjugates.
Paoletti LC; Kasper DL; Michon F; DiFabio J; Jennings HJ; Tosteson TD; Wessels MR
J Clin Invest; 1992 Jan; 89(1):203-9. PubMed ID: 1729272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
